Prevalence of and factors associated with post-traumatic stress disorder among French university students 1 month after the COVID-19 lockdown.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
27 05 2021
Historique:
received: 02 02 2021
accepted: 12 05 2021
revised: 05 05 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 22 6 2021
Statut: epublish

Résumé

The COVID-19 pandemic and quarantine measures have sparked debate regarding their traumatic nature. This cross-sectional study reports the prevalence rate of probable post-traumatic stress syndrome (PTSD) and associated factors among French university students. A total of 22,883 students completed the online questionnaire. The prevalence rate of probable PTSD, assessed using the PTSD Checklist for DSM-5, was 19.5% [19.0-20.0]. Female (1.32 [1.21-1.45]) or non-binary gender (1.76 [1.35-2.31]), exposure to a non-COVID-19-related traumatic event (3.37 [3.08-3.67]), having lived through quarantine alone (1.22 [1.09-1.37]), poor quality of social ties (2.38 [2.15-2.62]), loss of income (1.20 [1.09-1.31]), poor quality housing (1.90 [1.59-2.26]), low-quality of the information received (1.50 [1.35-1.66]) and a high level of exposure to COVID-19 (from 1.38 [1.24-1.54] to 10.82 [2.33-76.57] depending on the score) were associated with PTSD. Quarantine was considered potentially traumatic by 78.8% of the students with probable PTSD. These findings suggest the pandemic context and lockdown measures could have post-traumatic consequences, stimulating debate on the nosography of PTSD.

Identifiants

pubmed: 34045442
doi: 10.1038/s41398-021-01438-z
pii: 10.1038/s41398-021-01438-z
pmc: PMC8157529
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

327

Références

J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
Clin Psychol Psychother. 2020 May;27(3):384-395
pubmed: 32415733
Can J Psychiatry. 2003 Feb;48(1):56-61
pubmed: 12635566
J Am Acad Child Adolesc Psychiatry. 2020 Nov;59(11):1218-1239.e3
pubmed: 32504808
Int J Law Psychiatry. 2020 Jul - Aug;71:101594
pubmed: 32768101
Ann Epidemiol. 2007 Sep;17(9):643-53
pubmed: 17553702
Acta Obstet Gynecol Scand. 2020 Jul;99(7):848-855
pubmed: 32449178
J Affect Disord. 2020 Sep 1;274:1-7
pubmed: 32405111
Lancet Psychiatry. 2014 Sep;1(4):269-77
pubmed: 26360860
Encephale. 2008 Dec;34(6):577-83
pubmed: 19081454
Psychiatry Res. 2020 May;287:112921
pubmed: 32240896
JAMA Netw Open. 2020 Oct 1;3(10):e2025591
pubmed: 33095252
J Clin Psychiatry. 2020 Dec 8;82(1):
pubmed: 33296149
J Health Psychol. 2020 Aug;25(9):1164-1175
pubmed: 32627606
J Abnorm Psychol. 2018 Oct;127(7):623-638
pubmed: 30211576
Clin Psychol Rev. 2018 Jul;63:41-55
pubmed: 29902711
Int J Equity Health. 2004 May 6;3(1):3
pubmed: 15128460
Psychiatry Res. 2020 Oct;292:113297
pubmed: 32707218
Front Psychiatry. 2020 Aug 07;11:803
pubmed: 32848958
J Consult Clin Psychol. 2000 Oct;68(5):748-66
pubmed: 11068961
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
PLoS One. 2016 Oct 10;11(10):e0161645
pubmed: 27723815
J Trauma Stress. 2020 Oct;33(5):866-868
pubmed: 33007141
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Int Psychogeriatr. 2013 Jun;25(6):1007-12
pubmed: 23433477

Auteurs

Marielle Wathelet (M)

Fédération de Recherche en Psychiatrie et Santé Mentale des Hauts-de-France, F-59000, Lille, France.
Centre National de Ressources et de Résilience Lille-Paris (CN2R), F-59000, Lille, France.
Department of Psychiatry, CHU Lille, F-59000, Lille, France.
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.

Thomas Fovet (T)

Centre National de Ressources et de Résilience Lille-Paris (CN2R), F-59000, Lille, France.
Department of Psychiatry, CHU Lille, F-59000, Lille, France.
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.

Améliane Jousset (A)

Department of Public Health, CHU Lille, F-59000, Lille, France.

Stéphane Duhem (S)

Fédération de Recherche en Psychiatrie et Santé Mentale des Hauts-de-France, F-59000, Lille, France.
Centre National de Ressources et de Résilience Lille-Paris (CN2R), F-59000, Lille, France.
Department of Psychiatry, CHU Lille, F-59000, Lille, France.
Univ. Lille, Inserm, CHU Lille, CIC1403 - Clinical Investigation Center, Lille, France.

Enguerrand Habran (E)

Fonds FHF Recherche et Innovation, F-75993, Paris, France.

Mathilde Horn (M)

Department of Psychiatry, CHU Lille, F-59000, Lille, France.
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.

Christophe Debien (C)

Centre National de Ressources et de Résilience Lille-Paris (CN2R), F-59000, Lille, France.
Department of Psychiatry, CHU Lille, F-59000, Lille, France.

Charles-Edouard Notredame (CE)

Department of Psychiatry, CHU Lille, F-59000, Lille, France.
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.

Thierry Baubet (T)

Centre National de Ressources et de Résilience Lille-Paris (CN2R), F-59000, Lille, France.
AP-HP, Avicenne Hospital, Department of Infant, Child and Adolescent Psychiatry, Sorbonne Paris Nord University, CESP, Bobigny, F-93000, France.

Guillaume Vaiva (G)

Centre National de Ressources et de Résilience Lille-Paris (CN2R), F-59000, Lille, France.
Department of Psychiatry, CHU Lille, F-59000, Lille, France.
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France.

Fabien D'Hondt (F)

Centre National de Ressources et de Résilience Lille-Paris (CN2R), F-59000, Lille, France. fabien.d-hondt@univ-lille.fr.
Department of Psychiatry, CHU Lille, F-59000, Lille, France. fabien.d-hondt@univ-lille.fr.
Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, F-59000, Lille, France. fabien.d-hondt@univ-lille.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH